Stepping down from combination asthma therapy: The predictors of outcome

Stepping down from combination asthma therapy (inhaled corticosteroids (ICS) + long-acting β2 agonists (LABA)) is often avoided due to fear of exacerbations, which may lead to overmedication in well-controlled asthma. A better knowledge about the predictors of outcome might encourage clinicians to start stepping down more often than previously.
Source: Respiratory Medicine CME - Category: Respiratory Medicine Authors: Source Type: research